Strategic Partnering

We’re on a mission to make cancer more detectable.

Pioneering molecular MRI for cancer detection

We’re developing the world’s first molecular MRI contrast agents to improve the detection of cancer using bio-safe superparamagnetic nanoparticles.

Surgical outcomes improve, treatments are more successful, and survival rates increase with early detection.

By combining high-sensitivity magnetic resonance imaging (MRI) with targeted nanoparticle technology, we aim to make the detection and management of diseases like cancer better and safer for patients.

Let’s discuss partnership opportunities

Imagion Biosystems is actively seeking strategic partners to accelerate the development of our MagSense® product portfolio.

To connect with our team, please contact us via email at

Seeking partners in all areas of our business


We are developing proprietary imaging products.

Example Applications:​

    • MagSense® tumor detection: breast, prostate, ovarian, and pancreatic ​
    • Treatment monitoring ​
    • Bloodpool imaging
    • Detection and therapy

OEM Products

We supply nanoparticles to third parties developing biomedical products.​

Example Applications:​

    • Magnetic Hyperthermia ​
    • Human and animal vaccines ​
    • Cancer screening and treatments
About Imagion Biosystems


PrecisionMRX® nanoparticles are available to academic institutions for research purposes.​

Multiple coating types available:

    • Carboxylic Acid Functionalized​
    • Dextran-Coated​
    • mPEG Coated​
    • Oleic Acid Coated

Strategic Interests with MagSense®

MagSense® Collaboration

  • We have developed our MagSense® portfolio of targeted molecular MRI contrast agents and are interested in co-development and commercial partnerships to advance those products.

MagSense® Companion Dx

  • ​Virtually any targeted therapeutic addressing extracellular targets (e.g., mAb or small molecule) could also be used to target a MagSense® Companion Dx product to accelerate clinical development and improve cost-effectiveness.

  • ​We are interested in partnering with pharma to develop MagSense® imaging agents that would improve clinical study and treatment outcomes.
Interested in a collaboration? Inquire about potential partnerships:

World class scientific collaborations & partnerships

Interested in a collaboration?

Inquire about potential partnership opportunities.